265 related articles for article (PubMed ID: 30868690)
1. Trends in mortality from cutaneous malignant melanoma in Spain (1982-2016): sex-specific age-cohort-period effects.
Gutiérrez-González E; López-Abente G; Aragonés N; Pollán M; Pastor-Barriuso R; Sánchez MJ; Pérez-Gómez B
J Eur Acad Dermatol Venereol; 2019 Aug; 33(8):1522-1528. PubMed ID: 30868690
[TBL] [Abstract][Full Text] [Related]
2. Has mortality from malignant melanoma stopped rising in Spain? Analysis of trends between 1975 and 2001.
Cayuela A; Rodríguez-Domínguez S; Lapetra-Peralta J; Conejo-Mir JS
Br J Dermatol; 2005 May; 152(5):997-1000. PubMed ID: 15888159
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous malignant melanoma mortality in Spain from 1979 to 2018. Trends and new perspectives in the immunotherapy era.
Durán-Romero AJ; Sendín-Martin M; Conejo-Mir J; Pereyra-Rodriguez JJ
J Eur Acad Dermatol Venereol; 2021 Apr; 35(4):884-891. PubMed ID: 33030772
[TBL] [Abstract][Full Text] [Related]
4. Effect of age, birth cohort and period of death on skin melanoma mortality in Spain, 1975 through 2004.
Cayuela A; Rodríguez-Domínguez S; Vigil E; Conejo-Mir JS
Int J Cancer; 2008 Feb; 122(4):905-8. PubMed ID: 17957799
[TBL] [Abstract][Full Text] [Related]
5. Trends in burn injury mortality in Spain (1979-2018): Sex-specific age-cohort-period effects.
García-Díaz A; Durán-Romero AJ; PurificaciónGacto-Sánchez ; Carbajal-Guerrero J; Gómez-Cía T; Pereyra-Rodríguez JJ
Burns; 2021 May; 47(3):714-720. PubMed ID: 32878699
[TBL] [Abstract][Full Text] [Related]
6. Gender differences in rising trends in cutaneous malignant melanoma in Spain, 1975-98.
Nieto A; Ruiz-Ramos M; Abdel-Kader L; Conde M; Camacho F
Br J Dermatol; 2003 Jan; 148(1):110-6. PubMed ID: 12534603
[TBL] [Abstract][Full Text] [Related]
7. Trends in mortality from cutaneous malignant melanoma in Belgium.
Bleyen L; De Bacquer D; Myny K; Brochez L; Naeyaert JM; De Backer G
Int J Epidemiol; 1999 Feb; 28(1):40-5. PubMed ID: 10195662
[TBL] [Abstract][Full Text] [Related]
8. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994.
Giles GG; Armstrong BK; Burton RC; Staples MP; Thursfield VJ
BMJ; 1996 May; 312(7039):1121-5. PubMed ID: 8620126
[TBL] [Abstract][Full Text] [Related]
9. Mortality trends in cutaneous malignant melanoma in Spain, 1967-1986.
Pollán M; López-Abente G
Cancer Epidemiol Biomarkers Prev; 1993; 2(6):545-50. PubMed ID: 8268771
[TBL] [Abstract][Full Text] [Related]
10. Mortality trend of cutaneous melanoma in Montenegro from 1990-2018.
Nedovic Vukovic M; Terzic Z; Golubovic M; Bojic M; Bukumiric Z
Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3463-3472. PubMed ID: 38766804
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous malignant melanoma mortality in Andalusia from 1979 to 2018. Toward new perspectives?
Ortiz-Álvarez J; Durán-Romero AJ; Hernández-Rodríguez JC; Sendín-Martin M; Conejo-Mir J; Pereyra-Rodriguez JJ
Dermatol Ther; 2021 Jan; 34(1):e14715. PubMed ID: 33368880
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969-1993.
Bulliard JL; Cox B
Int J Epidemiol; 2000 Jun; 29(3):416-23. PubMed ID: 10869312
[TBL] [Abstract][Full Text] [Related]
14. Trends in mortality from malignant cutaneous melanoma in The Netherlands, 1950-1988.
Nelemans PJ; Kiemeney LA; Rampen FH; Straatman H; Verbeek AL
Eur J Cancer; 1992; 29A(1):107-11. PubMed ID: 1445725
[TBL] [Abstract][Full Text] [Related]
15. Secular trends in incidence and mortality of bladder cancer in China, 1990-2017: A joinpoint and age-period-cohort analysis.
Liu X; Jiang J; Yu C; Wang Y; Sun Y; Tang J; Chen T; Bi Y; Liu Y; Zhang ZJ
Cancer Epidemiol; 2019 Aug; 61():95-103. PubMed ID: 31176961
[TBL] [Abstract][Full Text] [Related]
16. Malignant melanoma in Europe: changes in mortality rates (1970-90) in European Community countries.
Balzi D; Carli P; Geddes M
Cancer Causes Control; 1997 Jan; 8(1):85-92. PubMed ID: 9051327
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group.
MacKie RM; Hole D; Hunter JA; Rankin R; Evans A; McLaren K; Fallowfield M; Hutcheon A; Morris A
BMJ; 1997 Nov; 315(7116):1117-21. PubMed ID: 9374883
[TBL] [Abstract][Full Text] [Related]
18. Long-term trends in pancreatic cancer mortality in Spain (1952-2012).
Seoane-Mato D; Nuñez O; Fernández-de-Larrea N; Pérez-Gómez B; Pollán M; López-Abente G; Aragonés N
BMC Cancer; 2018 Jun; 18(1):625. PubMed ID: 29866063
[TBL] [Abstract][Full Text] [Related]
19. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia.
de Vries E; Bray FI; Coebergh JW; Parkin DM
Int J Cancer; 2003 Oct; 107(1):119-26. PubMed ID: 12925966
[TBL] [Abstract][Full Text] [Related]
20. An analysis of trends in mortality from malignant melanoma of the skin in Australia.
Holman CD; James IR; Gattey PH; Armstrong BK
Int J Cancer; 1980 Dec; 26(6):703-9. PubMed ID: 7216539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
